Stay updated on Tiragolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab in Lung Cancer Clinical Trial page.

Latest updates to the Tiragolumab in Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check42 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check56 days agoChange DetectedThe website has added new actual dates and a revision update to v2.14.1, while removing several estimated dates and the previous revision v2.14.0.SummaryDifference0.5%
- Check63 days agoChange DetectedThe study has added new locations across various countries, including multiple sites in Brazil, China, and Europe, while reducing the total number of locations from 154 to 141 and updating the revision from v2.13.3 to v2.14.0.SummaryDifference30%
- Check92 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
Stay in the know with updates to Tiragolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab in Lung Cancer Clinical Trial page.